Amova Asset Management Americas, Inc.
Source: SEC Form 13F · as of Mar 2026Amova Asset Management Americas, Inc. holds 11 biotech & pharma companies tracked by BioSniper, totaling $191.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$191.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Beam Therapeutics Inc. (BEAM)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| BEAMBeam Therapeutics Inc. | 3,825,585 | $91.2M |
| NTLAIntellia Therapeutics, Inc. | 1,973,061 | $25.3M |
| ADPTAdaptive Biotechnologies Corp | 1,595,370 | $22.1M |
| NRIXNurix Therapeutics, Inc. | 1,181,146 | $18.3M |
| RXRXRECURSION PHARMACEUTICALS, INC. | 5,419,221 | $16.6M |
| IONSIONIS PHARMACEUTICALS INC | 81,696 | $6.1M |
| ABSIAbsci Corporation | 1,346,774 | $4.0M |
| CNTNCanton Strategic Holdings, Inc. | 728,167 | $2.4M |
| CMPSCOMPASS Pathways plc | 368,828 | $2.0M |
| ATAIAtai Beckley N.V. | 567,576 | $2.0M |
| INCYIncyte Corp. | 13,623 | $1.3M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.